KLK3 and prostate carcinoma: The American Cancer Society (ACS) systematically reviewed the studies in the literature that assessed the PSA test performance.21,22 In a pooled analysis, the estimated sensitivity of a PSA cutoff of 4.0 ng/mL was 21% for detecting any prostate cancer and the estimated specificity was 91%.